前列腺MRI对MSKCC根治性前列腺切除术前列线图的增量价值有限
本研究回顾性分析236例根治性前列腺切除术前接受前列腺MRI的患者,比较MSKCC列线图单独与联合MRI对器官局限性疾病、包膜外侵犯、精囊侵犯和淋巴结受累的预测效能。结论认为前列腺MRI与MSKCC列线图联合模型不提供额外风险区分。
要点
- MSKCC+MRI联合模型对器官局限性疾病、包膜外侵犯、精囊侵犯和淋巴结受累的ΔAUC均无显著改善。
- 评估前列腺MRI作为预测工具时应与临床风险分层模型联合,而非独立使用。
核心结论
- 前列腺MRI与MSKCC列线图联合模型相比单独MSKCC列线图模型在风险区分上无额外获益。
主要发现
- 联合模型对精囊侵犯ΔAUC 0.63(P=0.63)。
临床怎么用
- 评估前列腺MRI作为预测工具时应与MSKCC等临床风险分层模型联合使用,而非独立使用。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the incremental value of prostate magnetic resonance imaging (MRI) when used in combination with the currently available preoperative risk stratification tool, the Memorial Sloan Kettering Cancer Center (MSKCC) preradical prostatectomy nomogram. MATERIALS AND METHODS: We reviewed our institutional database of prostate MRI performed before radical prostatectomy between December 2014 and March 2016 (n = 236). We generated a logistic regression model based on observed final pathology results and the MSKCC nomogram predictions for organ-confined disease, extracapsular extension (ECE), seminal vesicle invasion, and lymph node involvement (LNI) ("MSKCC only"). We then generated a combined regression model incorporating both the MSKCC nomogram prediction with the degree of prostate MRI suspicion ("MSKCC + MRI"). Receiver operating characteristic curves were generated, and the area under the curves (AUCs) were compared. RESULTS: When independently examining the MSKCC nomogram predicted risk and the degree of prostate MRI suspicion, MRI was a predictor for ECE (odds ratio 2.8, P <.01) and LNI (odds ratio 5.6, P = .01). When examining the "MSKCC + MRI" and "MSKCC only" models, the incremental benefit in risk discrimination from the combined model ("MSKCC + MRI") was not significant for organ-confined disease, ECE, seminal vesicle invasion, or LNI (ΔAUC +0.03, P = .10; ΔAUC +0.03, P = .08; ΔAUC 0.63, P = .63; ΔAUC +0.04, P = .42; respectively). CONCLUSION: A combined model with prostate MRI and the MSKCC nomogram provides no additional risk discrimination over the MSKCC nomogram-based model alone. Evaluation of prostate MRI as a predictive tool should be performed in combination with, not independent of, these clinical risk stratification models.
引用
- Weaver JK, Kim EH, Vetter JM, et al. Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram. Urology. 2017. PMID: 29217354. doi:10.1016/j.urology.2017.10.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。